Kinapse goes from strength to strength
Press Release | Published 11th June 2018
The life sciences consultancy has seen another year of double-digit growth, major client wins, new hires and promotions.
Multi-national life sciences consultancy Kinapse, which provides practical and clearly measurable ‘Advise, Build, Operate’ services to some of the largest and fastest-growing pharmaceutical organisations in the world, has reported another year of strong organic double-digit growth. This is thanks to some major client wins, supported by investment in a series of significant appointments and promotions to further strengthen the company’s senior leadership team.
Recent new hires include two new VPs of Advisory Services: Nicholas Lakin, in Europe, who joined in January from the role as European Head of R&D Consulting at Cognizant; and Mike Keech, in the US, who joined late last year from Lachman Consultant Services in Long Island, New York.
VP Advisory Services
VP Advisory Services
Kinapse has also made a number of senior promotions, further bolstering its leadership. Stuart Donald has assumed the role of Head of Operational Services; Stuart Goodall is Head of Regulatory; Helen Jeetley is Head of Pharmacovigilance; and Pooja Phogat is Head of Development Operations.
Head of Operational Services
Head of Regulatory
Head of Pharmacovigilance
Head of Development Operations
From strength to strength
Reflecting on the company’s healthy and sustained momentum, Head of Group Business Development, Adam Sherlock, who joined Kinapse last October, commented, “These appointments and promotions further strengthen the organisation’s position, in anticipation of continuing robust growth in the current financial year.”
“This strong growth is being driven by the accelerating maturation of operational services outsourcing, the impact of greater regulation, and the competitive demand to bring more products to more markets more effectively,” he explained.
“The appeal of our proposition to clients – whether they are substantial global players or fast-growing contenders with big ambitions – is that our services can take them from end to end across the drug development and commercialisation lifecycle. We’re the solution to all of the challenges currently faced by life sciences organisations, with the experience, best practices and complete advisory, implementation and operational services to support them in the real world.”
Kinapse works with 19 of the top 25 pharma companies as well as many of the fastest-growing life sciences businesses in the global market today. Founded in 2005 by professionals from the biopharmaceutical sector, Kinapse’s highly skilled talent pool combines 540 Master’s degrees in Life Sciences and more than 4,000 years’ industry experience.
“We’ve had another fantastic year, business is growing, our leadership is as broad as it is strong – we’re in a great place,” Adam added. “With the best possible team in place, we look forward to more of the same.”
Book a 1 to 1 with the Kinapse team at DIA 2018 – June 24-28, Boston
Throughout the 2018 DIA conference, Kinapse’s Advisory and Operational experts will be on hand to discuss your challenges and objectives. This is a perfect opportunity to come along and meet the team and get some insights and advice on your projects and programs. To schedule a one-on-one consultation with a Kinapse advisory or operational expert, email us at firstname.lastname@example.org and we’ll get it set up or simply stop by our booth during the conference. You’ll find us at booth #745.